Waterloo Researchers Develop Nanomedicine Technology That Could Help in the Battle Against Antibiotic Resistance

University of Waterloo researchers have developed a new technology that encapsulates a full course of antibiotics in one tiny dose and supplies on-demand treatment of the precise amount of medication needed by a patient to fight an infection. 

The targeted nanomedicine drug-delivery technology was tested in two studies on two bacterial strains that negatively impact millions of people worldwide: Streptococcus pneumoniae and Gardnerella vaginalis. Streptococcus pneumoniae causes meningitis, sepsis and bacterial pneumonia, potentially fatal conditions, while Gardnerella vaginalis is mainly associated with bacterial vaginosis.